These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 24310907)

  • 1. Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy.
    Valera E; Ubhi K; Mante M; Rockenstein E; Masliah E
    Glia; 2014 Feb; 62(2):317-37. PubMed ID: 24310907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophy.
    Rockenstein E; Ubhi K; Inglis C; Mante M; Patrick C; Adame A; Masliah E
    Neuroreport; 2012 Mar; 23(4):259-64. PubMed ID: 22314685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy.
    Hoffmann A; Ettle B; Battis K; Reiprich S; Schlachetzki JCM; Masliah E; Wegner M; Kuhlmann T; Riemenschneider MJ; Winkler J
    Brain Pathol; 2019 May; 29(3):380-396. PubMed ID: 30444295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
    Shults CW; Rockenstein E; Crews L; Adame A; Mante M; Larrea G; Hashimoto M; Song D; Iwatsubo T; Tsuboi K; Masliah E
    J Neurosci; 2005 Nov; 25(46):10689-99. PubMed ID: 16291942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy.
    Bassil F; Fernagut PO; Bezard E; Pruvost A; Leste-Lasserre T; Hoang QQ; Ringe D; Petsko GA; Meissner WG
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9593-8. PubMed ID: 27482103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
    Mandler M; Valera E; Rockenstein E; Mante M; Weninger H; Patrick C; Adame A; Schmidhuber S; Santic R; Schneeberger A; Schmidt W; Mattner F; Masliah E
    Mol Neurodegener; 2015 Mar; 10():10. PubMed ID: 25886309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.
    Mandel RJ; Marmion DJ; Kirik D; Chu Y; Heindel C; McCown T; Gray SJ; Kordower JH
    Acta Neuropathol Commun; 2017 Jun; 5(1):47. PubMed ID: 28619074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy.
    Ubhi K; Inglis C; Mante M; Patrick C; Adame A; Spencer B; Rockenstein E; May V; Winkler J; Masliah E
    Exp Neurol; 2012 Apr; 234(2):405-16. PubMed ID: 22281106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human alpha-synuclein overexpressing MBP29 mice mimic functional and structural hallmarks of the cerebellar subtype of multiple system atrophy.
    Mészáros L; Riemenschneider MJ; Gassner H; Marxreiter F; von Hörsten S; Hoffmann A; Winkler J
    Acta Neuropathol Commun; 2021 Apr; 9(1):68. PubMed ID: 33853667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy.
    Spencer B; Valera E; Rockenstein E; Trejo-Morales M; Adame A; Masliah E
    Mol Neurodegener; 2015 Sep; 10():48. PubMed ID: 26394760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy.
    Laferrière F; He X; Zinghirino F; Doudnikoff E; Faggiani E; Meissner WG; Bezard E; De Giorgi F; Ichas F
    Cells; 2020 Oct; 9(11):. PubMed ID: 33138150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathies.
    Kisos H; Pukaß K; Ben-Hur T; Richter-Landsberg C; Sharon R
    PLoS One; 2012; 7(10):e46817. PubMed ID: 23077527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy.
    Nakayama K; Suzuki Y; Yazawa I
    Am J Pathol; 2009 Apr; 174(4):1471-80. PubMed ID: 19286568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.
    Stemberger S; Poewe W; Wenning GK; Stefanova N
    Exp Neurol; 2010 Aug; 224(2):459-64. PubMed ID: 20493840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.
    Ubhi K; Rockenstein E; Mante M; Inglis C; Adame A; Patrick C; Whitney K; Masliah E
    J Neurosci; 2010 May; 30(18):6236-46. PubMed ID: 20445049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of α-synuclein oligomers and phosphorylated α-synuclein aggregates.
    Yamaguchi H; Nishimura Y; Matsuse D; Sekiya H; Masaki K; Tanaka T; Saiga T; Harada M; Kira YI; Dickson DW; Fujishima K; Matsuo E; Tanaka KF; Yamasaki R; Isobe N; Kira JI
    Brain Behav Immun; 2024 Oct; 121():122-141. PubMed ID: 38986725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy.
    Kragh CL; Gysbers AM; Rockenstein E; Murphy K; Halliday GM; Masliah E; Jensen PH
    Neurobiol Dis; 2014 Mar; 63():171-83. PubMed ID: 24361600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy.
    Valera E; Spencer B; Fields JA; Trinh I; Adame A; Mante M; Rockenstein E; Desplats P; Masliah E
    Acta Neuropathol Commun; 2017 Jan; 5(1):2. PubMed ID: 28057080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
    Ettle B; Kerman BE; Valera E; Gillmann C; Schlachetzki JC; Reiprich S; Büttner C; Ekici AB; Reis A; Wegner M; Bäuerle T; Riemenschneider MJ; Masliah E; Gage FH; Winkler J
    Acta Neuropathol; 2016 Jul; 132(1):59-75. PubMed ID: 27059609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to α-synuclein inclusions.
    Radford R; Rcom-H'cheo-Gauthier A; Wong MB; Eaton ED; Quilty M; Blizzard C; Norazit A; Meedeniya A; Vickers JC; Gai WP; Guillemin GJ; West AK; Dickson TC; Chung R; Pountney DL
    Mol Cell Neurosci; 2015 Mar; 65():68-81. PubMed ID: 25731829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.